Fundraising FoxDisperSol Technologies
Georgetown, US · Founded 2007 · Texas LLC · 1 known investors
Find your way into DisperSol Technologies
Sign up to see every warm intro you have to DisperSol Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DisperSol Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SK
GY
Gershon YanivExecutiveGershon Yaniv holds a PhD in mechanical and aerospace engineering from Technion and an executive MBA from Arizona State University. He has held senior leadership roles across multiple industries, including CEO of DisperSol Technologies (pharmaceutical processing), CEO and COO of IntegriCo Composites (composite manufacturing), President of Simula Automotive Safety Devices (automotive safety systems), and Director of R&D at Simula Technologies (aerospace and defense armor systems).
DS
Dustin SmithExecutive
ER
Edward R. HobartExecutive
Board
JS
Jeffrey SambergBoard director
CB
Chris BroughBoard director
JM
James MackBoard director
Investors · 1
Research Corporation TechnologiesreportedTucson
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$36.4M disclosed across 5 rounds · 2012–2020
▶$4.7MraisedOct 2020 · 3 investors · PharmaceuticalsRule 506(b)
▶$4.7MraisedOct 2020 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James MackDirector
- Gershon YanivDirector
- Jeffrey D. SambergDirector
- Shaun KirkpatrickDirector
- Edward M. Rudnic, Ph.D.Executive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.7M
- First sale
- Oct 2020
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$16MraisedJan 2018 · 4 investors · PharmaceuticalsRule 506(b)
▶$16MraisedJan 2018 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey D. SambergDirector
- James MackDirector
- Gershon YanivDirector
- Edward M. Rudnic, Ph.D.Executive Officer, Director
- Shaun KirkpatrickDirector
- Offering amount
- $27.3M
- Amount sold
- $16M
- First sale
- Jan 2018
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$12MraisedFeb 2016 · 3 investors · PharmaceuticalsRule 506(b)
▶$12MraisedFeb 2016 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shaun KirkpatrickExecutive Officer, Director
- James MackDirector
- Gershon YanivExecutive Officer, Director
- Dustin SmithExecutive Officer
- Jeffrey SambergDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$3MraisedMar 2014 · 12 investors · PharmaceuticalsRule 506(b)
▶$3MraisedMar 2014 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chris BroughDirector
- Edward HobartExecutive Officer, Director
- Gershon YanivExecutive Officer, Director
- Jeffrey D. SambergDirector
- Offering amount
- $7.5M
- Amount sold
- $3M
- Finders' fees
- $150K
- First sale
- Feb 2014
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$641.7KraisedFeb 2012 · 11 investors · PharmaceuticalsRule 506(b)
▶$641.7KraisedFeb 2012 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gershon YanivExecutive Officer, Director
- Chris BroughDirector
- Jeffrey D. SambergDirector
- Edward R. HobartExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $641.7K
- First sale
- Jan 2012
- Incorporated
- Limited Liability Company, Texas, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are DisperSol Technologies's investors?
- DisperSol Technologies's investors include Research Corporation Technologies.
- How much funding has DisperSol Technologies raised?
- DisperSol Technologies has disclosed $36.4M raised across 5 rounds.
- Where is DisperSol Technologies headquartered?
- DisperSol Technologies is headquartered in Georgetown, US.